Detalhe da pesquisa
1.
Estimate of the total costs of allergic rhinitis in specialized care based on real-world data: the FERIN Study.
Allergy
; 72(6): 959-966, 2017 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-27886391
2.
Cost minimisation analysis of fingolimod vs natalizumab as a second line of treatment for relapsing-remitting multiple sclerosis.
Neurologia
; 29(4): 210-7, 2014 May.
Artigo
Inglês, Espanhol
| MEDLINE | ID: mdl-24161412
3.
A cost-utility analysis of increasing percutaneous coronary intervention use in elderly patients with acute coronary syndromes in six European countries.
Eur J Prev Cardiol
; 28(4): 408-417, 2021 05 08.
Artigo
Inglês
| MEDLINE | ID: mdl-33966078
4.
Sacral neuromodulation for the treatment of fecal incontinence: analysis of cost-effectiveness.
Dis Colon Rectum
; 53(12): 1661-9, 2010 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-21178862
5.
Cost Effectiveness Analysis Of Ticagrelor Versus Generic Clopidogrel In The Treatment Of Patients With Acute Coronary Syndrome In Spain.
Value Health
; 17(7): A491, 2014 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-27201460
6.
Economic Considerations On the Use of Mifamurtide In the Treatment of Osteosarcoma In Spain.
Value Health
; 17(7): A526-7, 2014 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-27201662
7.
Clinical and cost effectiveness of sacral nerve stimulation for faecal incontinence.
Br J Surg
; 95(8): 1037-43, 2008 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-18574847
8.
Cost-effectiveness analysis of sunitinib in patients with metastatic and/or unresectable gastrointestinal stroma tumours (GIST) after progression or intolerance with imatinib.
Clin Transl Oncol
; 10(12): 831-9, 2008 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-19068454
9.
Analysis of the implementation of a personalized care model in diabetes mellitus as an example of chronic disease with information and communication technology support.
Expert Rev Pharmacoecon Outcomes Res
; 17(2): 141-148, 2017 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-28403728
10.
Iatrogenic cost factors incorporating mild and moderate adverse events in the economic comparison of aceclofenac and other NSAIDs.
Pharmacoeconomics
; 19(7): 779-90, 2001.
Artigo
Inglês
| MEDLINE | ID: mdl-11548913
11.
Cost-effectiveness analysis of different strategies for treating duodenal ulcer. Helicobacter pylori eradication versus antisecretory treatment.
Pharmacoeconomics
; 11(4): 367-76, 1997 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-10166411
12.
Reliability of the Spanish version of the Nottingham Health Profile in patients with stable end-stage renal disease.
Soc Sci Med
; 38(1): 153-8, 1994 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-8146706
13.
Cost-effectiveness impact of rivaroxaban versus new and existing prophylaxis for the prevention of venous thromboembolism after total hip or knee replacement surgery in France, Italy and Spain.
Thromb Haemost
; 110(5): 987-94, 2013 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-23965805
14.
Economic evaluation of the levonorgestrel-releasing intrauterine system for the treatment of dysfunctional uterine bleeding in Spain.
Eur J Obstet Gynecol Reprod Biol
; 154(1): 71-80, 2011 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-20951492
15.
The burden of hospital malnutrition in Spain: methods and development of the PREDyCES® study.
Nutr Hosp
; 25(6): 1020-4, 2010.
Artigo
Inglês
| MEDLINE | ID: mdl-21519775
16.
Análisis de minimización de costes entre fingolimod y natalizumab en segunda línea de tratamiento de esclerosis múltiple remitente-recurrente / Cost minimisation analysis of fingolimod vs natalizumab as a second line of treatment for relapsing-remitting multiple sclerosis
Neurología (Barc., Ed. impr.)
; 29(4): 210-217, mayo 2014. tab, graf
Artigo
Espanhol
| IBECS (Espanha) | ID: ibc-122417
17.
The burden of hospital malnutrition in Spain: methods and development of the PREDyCES® study / El coste de la desnutrición hospitalaria en España: método y desarrollo del estudio PREDyCES®
Nutr. hosp
; 25(6): 1020-1024, nov.-dic. 2010. tab
Artigo
Inglês
| IBECS (Espanha) | ID: ibc-94110
18.
[Evidence-based medicine, health costs and treatment of intra-abdominal infection]. / Medicina basada en la evidencia, costes sanitarios y tratamiento de la infección intraabdominal.
Enferm Infecc Microbiol Clin
; 17 Suppl 2: 86-94, 1999.
Artigo
Espanhol
| MEDLINE | ID: mdl-10605193
19.
[A cost-effectiveness analysis of strategies for the diagnosis-treatment of Helicobacter pylori-associated peptic ulcer in primary care]. / Análisis coste-efectividad de estrategias de diagnóstico-tratamiento del ulcus péptico asociados a Helicobacter pylori en atención primaria.
Aten Primaria
; 24(6): 344-51, 1999 Oct 15.
Artigo
Espanhol
| MEDLINE | ID: mdl-10596225
20.
Análisis de los costes y la efectividad del uso de cilostazol frente a naftidrofurilo y pentoxifilina en el tratamiento de la claudicación intermitente en España / Cost-effectiveness analysis of cilostazol vs naftidrofuryl and pentoxifylline for the treatment of intermittent claudication in Spain
Angiología
; 63(3): 103-107, mayo-jun. 2011. ilus, tab
Artigo
Espanhol
| IBECS (Espanha) | ID: ibc-101291